Amplia Therapeutics Limited
ATX.AX
Australian Securities Exchange0.16
AUD
+0.01
- -
Total Valuation
Amplia Therapeutics Limited carries a market capitalization of 79.56M, placing it among publicly traded companies globally.
| Market Cap | 79.56M |
| Enterprise Value | N/A |
Stock Price Statistics
Amplia Therapeutics Limited's stock has declined approximately -56.33803% over the past 52 weeks. The 50-day moving average sits at 0.14, while the 200-day moving average is 0.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -56.33803% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.14 |
| Average Volume (20 Days) | N/A |
Stock Splits
Amplia Therapeutics Limited's most recent stock split took place on April 19, 2024 with a 250:257 split ratio.
| Last Split Date | 4/19/2024 |
| Split Ratio | 250:257 |